LHDX News and Press, Lucira Health Inc. From 09/24/21

Cue Health (NASDAQ:HLTH) has priced its IPO of 12.5M shares of common stock at $16.00/share, for gross proceeds of $200M at a target valuation of around $2.4B. Nasdaq trading commences on September 24, 2021. Underwriters' over-allotment is an additional 1.875M shares. Closing date i...

EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, t...

Gainers: Aditxt ADTX +76%, BioLife Solutions (NASDAQ:BLFS) +15%, Virpax Pharmaceuticals (NASDAQ:VRPX) +10%, Flexion Therapeutics FLXN +9%, Rafael (NYSE:RFL) +7%. Losers: Cassava Sciences SAVA -22%, 111 (NASDAQ:YI) -15%, Owlet (NYSE:OWLT) ...

Life science professional expands Lucira’s management team Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectio...

Volatility comes with the territory when you invest in biotech stocks. But sometimes the pullbacks with these stocks present fantastic buying opportunities for long-term investors. We asked three Motley Fool contributors which beaten-down biotech stocks they thought were great picks to ...

The dream of truly being in a post-Covid-19 world is finally beginning to fade away with the rise of the Delta variant. The future appears more and more set on “management of an endemic pathogen” than the eradication of this foe. It will always find somewhere to hide out and mut...

Image source: The Motley Fool. Lucira Health, Inc. (NASDAQ: LHDX) Q2 2021 Earnings Call Aug 12, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Lucira Health, Inc. (LHDX) Q2 2021 Earnings Call Transcript

Lucira Health, Inc. (LHDX) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Hannah Jeffrey – Gilmartin Group Erik Engleson – President and Chief Executive Officer Dan George – Chief Financial Officer Conference Call Participants Griffin Sor...

EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported ...

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)